Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced the promotion of Jennifer Jarrett from Chief Business Officer and Chief Financial Officer to Chief Operating Officer. In this new role, Ms. Jarrett will be responsible for several key areas, including finance, investor relations, corporate communications, business and corporate development, strategic planning and human resources. Ms. Jarrett will also continue to be the Company’s Chief Financial Officer.
“Since joining Arcus, Jennifer has successfully built out our finance, investor relations and corporate communications functions and played a central role in our fundraising and business development activities,” said Terry Rosen, Ph.D., Chief Executive Officer at Arcus. “Jennifer’s promotion to Chief Operating Officer reflects a recognition of her outstanding leadership and the impact that she has had across the breadth of Arcus’s operations to date and our company’s increasing focus on portfolio prioritization and early commercial planning. We will benefit greatly from Jennifer’s extensive knowledge of the commercial landscape and the vision that she brings to the careful consideration of the numerous opportunities and challenges associated with the next-generation immuno-oncology agents we are advancing into and through clinical development.”
Ms. Jarrett joined Arcus in 2017 and has over 20 years of experience in biotechnology. Prior to joining Arcus, Ms. Jarrett was the Chief Financial Officer of Medivation, through its acquisition by Pfizer in September 2016; there, she was responsible for finance and accounting, investor relations, business development and information technology. Prior to Medivation, Ms. Jarrett spent 18 years in investment banking, most recently as a Managing Director in Citigroup’s Health Care Investment Banking Group, where she built and led their west coast biotechnology investment banking practice. Ms. Jarrett also serves on the Board of Directors of Arena Pharmaceuticals and Audentes Therapeutics. Ms. Jarrett received her M.B.A. from Stanford Graduate School of Business and her undergraduate degree in Economics from Dartmouth College.
- BMO Harris Financial Advisors Appoints New Chief Operating Officer
- Ivy Greaner Joins InvenTrust as the New Chief Operating Officer
- JetBlue Announces Senior Leadership Changes
- Boston Private Wealth Promotes Tom Anderson to Chief Operating Officer and Shannon Saccocia to Chief Investment Officer
- NCI Announces Key Executive Promotion